Precision Bio, Nova Synthetix to Collaborate on Ricin-Free Castor Plant Development | GenomeWeb

NEW YORK (GenomeWeb News) – Precision BioSciences and Nova Synthetix today announced a deal for the use of each other's technologies to generate "non-GM," ricin-free castor plants.

Precision Bio's Directed Nuclease Editor gene editing technology and Nova's proprietary plant transformation system will be used in work covered by the agreement. The DNE technology produces genome-editing enzymes that can "insert, remove, modify, and regulate essentially any gene in mammalian or plant cells," the firms noted in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.